According to a new report North America Implantable Medical Devices Market, published by KBV Research, the North America Implantable Medical Devices is expected grow at a CAGR of 6.2% during the forecast period. The US market dominated the North America Metal Implantable Medical Devices Market by Country in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 3.7% during the forecast period. The Canada market is expected to witness a CAGR of 6.7% during (2016 - 2022). Additionally, The Mexico market is expected to witness a CAGR of 5.8% during (2016 - 2022).
The Orthopedic Implants market dominated the US Implantable Medical Devices Market by Product in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 6.1 % during the forecast period. The Cardiovascular Implants market is expected to witness a CAGR of 5% during (2016 - 2022). Additionally, The Dental Implants market is expected to witness highest CAGR of 6% during (2016 - 2022). The Reconstructive joint replacements market dominated the US Implantable Medical Devices Market by Orthopedic Implants in 2015, and would continue to be a dominant market till 2022.
The Knee Replacements market is expected to witness a CAGR of 9.1% during (2016 - 2022). The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key influencing factors of the North AmericaImplantable Medical Devices have been discussed in the report along with the elaborated company profiles of Abbott Laboratories., Boston Scientific Corporation, Conmed Corporation, Johnson & Johnson, Medtronic Plc, Smith And Nephew Plc, Stryker Corporation, C.R. Bard, Inc., Cardinal health, Inc. and Globus Medical, Inc.
Full report : https://www.kbvresearch.com/north-america-implantable-medical-devices-market/
Global Implantable Medical Devices Market
Europe Implantable Medical Devices Market
Unique Offerings 
